News and Announcements
US Residential Fund Successfully Sold Properties in Accordance with New Strategic Direction
- Published February 07, 2017 9:14AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
US Residential Fund (USR) is pleased to announce the sale of 28 single family houses in Atlanta, Georgia. These specific properties were sold for US$3.95 million consistent with fair value.
As a result of these sales, the Fund has paid down US$2.2 million in relation to debt.
Prior to this transaction, the USR held 122 single family rental properties across the states of Georgia, Ohio and Texas.
To view USR’s graph in relation to pre- and post-sale along with a comment for the Managing Director please click here.
Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
